CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) shares fell 19.4% on Thursday. The company traded as low as C$3.95 and last traded at C$3.95. Approximately 1,000 shares changed hands during mid-day trading, an increase of 56% from the average daily volume of 640 shares. The stock had previously closed at C$4.90.
CanSino Biologics Price Performance
The company’s fifty day moving average price is C$3.98 and its two-hundred day moving average price is C$3.55.
CanSino Biologics Company Profile
CanSino Biologics Inc is a China-based biotechnology company focused on the research, development, manufacturing and commercialization of vaccines. The company develops vaccine technologies intended to address infectious diseases, with activities spanning early-stage research, clinical development, regulatory approval and commercial production.
CanSino’s portfolio includes Convidecia, an adenovirus-based COVID-19 vaccine, and Convidecia Air, an inhaled version designed for respiratory immunization.
Recommended Stories
- Five stocks we like better than CanSino Biologics
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
